News Image

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

Provided By GlobeNewswire

Last update: Nov 12, 2024

BERKELEY HEIGHTS, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today announced third quarter financial results and provided a business update.

Read more at globenewswire.com

CYCLACEL PHARMACEUTICALS INC

NASDAQ:CYCC (7/28/2025, 8:19:54 PM)

Premarket: 14.81 -0.58 (-3.77%)

15.39

-0.65 (-4.05%)


CYCLACEL PHARMACEUTICALS - CYCC 6 PERP

NASDAQ:CYCCP (7/28/2025, 8:19:54 PM)

4.51

-0.33 (-6.82%)



Find more stocks in the Stock Screener

CYCC Latest News and Analysis

Follow ChartMill for more